Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ487489-2,20
KB755,5756-3,26
PKN69,6469,7-4,77
Msft-4,31
Nokia3,693,7-2,65
IBM-2,28
Daimler AG39,7339,75-6,74
PFE-2,94
25.02.2020 1:37:51
Indexy online
AD Index online
select
AD Index online
 

  • 24.02.2020
Quest Diagnostcs (DGX, NY Consolidated)
Závěr k 24.2.2020 Změna (%) Změna (USD) Objem obchodů (ks)
112,34 -0,72 -0,81 956 709
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 25.02.2020
Popis společnosti
Obecné informace
Název společnostiQuest Diagnostics Inc
TickerDGX
Kmenové akcie:Ordinary Shares
RICDGX
ISINUS74834L1008
Prioritní akciePreference Shares
Poslední známé roční výsledky31.12.2019
Poslední známé čtvrtletní výsledky31.12.2019
Počet zaměstnanců k 31.12.2018 46 000
Akcie v oběhu k 31.12.2019 133 000 000
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice500 Plaza Dr
MěstoSECAUCUS
PSČ07094-3619
ZeměUnited States
Kontatní osobaShawn Bevec
Funkce kontaktní osobyVice President, Investor Relations
Telefon19 735 202 700
Fax13026555049
Kontatní telefon19 735 202 900

Business Summary: Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2019, Quest Diagnostics Inc revenues increased 3% to $7.73B. Net income applicable to common stockholders excluding extraordinary items increased 17% to $838M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Equity in earnings of equity method inve increase of 30% to $57M (earnings).
Odvětvová klasifikace
TRBC2009Healthcare Facilities / Services
TRBC2012Healthcare Facilities & Services - NEC
RBSS2004Healthcare Facilities
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICSMedical Laboratories
SICMedical Laboratories
SICMedical Laboratories



  • Poslední aktualizace: 25.02.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerStephen Rusckowski6101.01.201701.05.2012
Chief Financial Officer, Executive Vice PresidentMark Guinan5729.07.201329.07.2013
Executive Vice President, General DiagnosticsJames Davis5516.04.2013
Senior Vice President and Chief Information and Digital OfficerGabrielle Wolfson-18.02.201918.02.2019
Senior Vice President, General CounselMichael Prevoznik57
Senior Vice President - CommercialEverett Cunningham5215.10.201215.10.2012
Senior Vice President, Group Executive - Clinical Franchise Solutions and MarketingCatherine Doherty5601.01.1996
Senior Vice President - Advanced DiagnosticsCarrie Manner44
Vice President, Corporate Controller and Chief Accounting Officer and Principal Accounting OfficerMichael Deppe5301.04.201901.04.2019
Executive OfficerManuel Mendez-19.11.201907.10.2019